We studied compliance with antihypertensive treatment in elderly patients with cognitive impairment. 4 key findings →
Design: cohort study
Participants: 1,979
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
Late-life depressive symptoms have been extensively studied for their relationship with incident dementia, but have been typically assessed at a single timepoint. 4 key findings →
Participants: 3,325
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
Thyroid status was measured at baseline (1990-93), through assessment of serum antibodies to thyroid peroxidase (TPO-Abs, positive: >10 IU/ml), serum TSH levels, and when TSH was abnormal ( 4.0 mU/l), serum thyroxin levels (T4). 4 key findings →
Participants: 1,843
Evidence: low
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
55/100
✓ Peer-reviewed
alzhub usefulness score 55 out of 100.
·
Radiology
·
2019-04-23
Obesity has been associated with increased risk of accelerated cognitive decline and dementia, which suggests underlying neurobiological changes. 4 key findings →
Participants: 87
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
Greater fish and omega-3 (n-3) polyunsaturated fatty acid (PUFA) intake may reduce dementia risk; however, previous studies have reported conflicting results, which were largely based on short-term follow-up. 4 key findings →
Participants: 5,395
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
However, most people with dementia live in low-income and middle-income countries (LMICs), where dementia risk prediction research is almost non-existent and the ability of current models to predict dementia is unknown. 4 key findings →
Participants: 143
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
Immunity has been suggested to be important in the pathogenesis of dementia. 4 key findings →
Participants: 8,313
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
55/100
✓ Peer-reviewed
alzhub usefulness score 55 out of 100.
·
JAMA neurology
·
2017-12-01
Cognitive dysfunction is a common feature among patients with parkinsonism, including Parkinson disease (PD). 4 key findings →
Participants: 7,386
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
Neuronal degeneration and dopamine loss in the preclinical phase of Parkinson disease may produce subtle complaints before clinically recognizable symptoms emerge. 4 key findings →
Design: cohort study
Participants: 6,038
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
55/100
✓ Peer-reviewed
alzhub usefulness score 55 out of 100.
·
Neurology
·
2017-09-20
Within the prospective population-based Rotterdam Study, we measured serum magnesium levels in 9,569 participants, free from dementia at baseline (1997-2008). 4 key findings →
Participants: 9,569
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
54/100
✓ Peer-reviewed
alzhub usefulness score 54 out of 100.
·
Neurology
·
2011-02-02
Retinal vessels provide a unique opportunity to study both systemic and cerebrovascular disease. 4 key findings →
Participants: 5,553
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
Within the prospective population-based Rotterdam Study, we studied lifetime risk of dementia, stroke and parkinsonism between 1990 and 2016. 4 key findings →
Participants: 102
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
54/100
✓ Peer-reviewed
alzhub usefulness score 54 out of 100.
·
Stroke
·
2011-11-23
Most studies investigating the genetics of dementia have focused on Alzheimer disease, but little is known about the genetics of vascular dementia. 4 key findings →
Design: cohort study
Participants: 67
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
53/100
✓ Peer-reviewed
alzhub usefulness score 53 out of 100.
·
Stroke
·
2007-02-01
Vascular factors and stroke are associated with cognitive function and dementia. 4 key findings →
Design: cohort study
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
Several studies have associated physical activity with the risk of dementia, but mostly did so during short follow-up. 4 key findings →
Participants: 583
Evidence: low
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
Adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet has been linked to a decreased risk of dementia, but reverse causality and residual confounding by lifestyle may partly account for this link. 4 key findings →
Participants: 5,375
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
We determined whether higher endogenous estradiol levels were associated with lower risk of dementia in older men and women not using hormonal replacement therapy, using a case-cohort design within the Rotterdam Study, a population-based follow-up study on chronic diseases, including dementia, in 7983 subjects aged 55 years or older, and ongoing since 1990. 4 key findings →
Participants: 7,983
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
Between 1997 and 2016, we repeatedly assessed cognitive function with 5 tests in 9514 participants aged 45-90 years from the population-based Rotterdam Study. 4 key findings →
Participants: 9,514
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
53/100
✓ Peer-reviewed
alzhub usefulness score 53 out of 100.
·
Neurology
·
1999-02-01
We assessed the risk of dementia by educational level in a prospective population-based study. 4 key findings →
Design: cross-sectional
Evidence: low
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
Reliable population estimates of life expectancy with dementia are required for shaping health-care policy. 4 key findings →
Participants: 10,348
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
According to the vascular depression hypothesis, subclinical cerebrovascular disease can cause depression in older adults. 4 key findings →
Design: cross-sectional
Participants: 1,494
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
There is a wide interest in biomarkers that capture the burden of detrimental factors as these accumulate with the passage of time, i.e., increasing age. 4 key findings →
Participants: 1,961
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
Despite a common misconception, older adults engage in sexual behavior. 4 key findings →
Design: cross-sectional
Participants: 858
Evidence: low
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
Herpes simplex virus 1 (HSV1) is a neuroinvasive virus capable of entering the brain which makes it a candidate pathogen for increasing risk of dementia. 4 key findings →
Participants: 244
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
51/100
✓ Peer-reviewed
alzhub usefulness score 51 out of 100.
·
Stroke
·
2016-07-14
Improved short-term survival after stroke has necessitated quantifying risk and risk factors of long-term sequelae after stroke (ie, recurrent stroke and dementia). 4 key findings →
Participants: 1,237
Evidence: low
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
How the 0–100 score works — and why some entries are capped
This is alzhub's own score. It is not an official metric, not an impact factor,
and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a
scientist can tell a landmark trial from a conference abstract without having to already know the
difference. Every point comes from one of 20 components, all of them printed on the study itself,
so you can disagree with our arithmetic rather than having to trust the total.
- Journal tier up to 10 pts
- Journal's citation record up to 4 pts
- Study design up to 12 pts
- Strength of evidence up to 5 pts
- Peer-review validation up to 10 pts
- How recent up to 5 pts
- Sample size up to 4 pts
- Effect reported up to 3 pts
- Studied in people up to 3 pts
- Randomized / blinded up to 2 pts
- Times cited up to 7 pts
- Citations per year up to 5 pts
- Impact for its field and year up to 6 pts
- Cited by studies here up to 6 pts
- Still being cited up to 4 pts
- Senior author's track record up to 4 pts
- Institution's track record up to 3 pts
- Multicenter collaboration up to 3 pts
- Indexed in PubMed up to 2 pts
- Free to read up to 2 pts
Journals are placed in ordered tiers, never given a numeric impact factor — we
could not verify current impact factors from a source we control, and an invented one would be
worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science,
Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed
journal. A separate part scores how much the journal's own papers are cited, which tells the
tier-3 journals apart.
Two rules we don't bend. First, we never fill in a
missing value: if a record does not state a sample size or a design, that component scores
zero, and if we simply have no data for a part, such as a citation count, that part is left out and
the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed
article is capped at 16/100 and carries a warning chip — so a conference abstract or
a company press release can never outrank a peer-reviewed paper, no matter how good it looks.
We rank a rigorous null result — a good trial showing that something does not
work — above an early positive finding. Someone deciding whether to buy a supplement is served by
that, and the rigour is already counted by the design and journal components.
The score is computed from the published data alone and is
reproducible: the same file always yields the same numbers.
See the whole rubric drawn out →
— four charts covering all 32,580 studies: how the scores are spread and where the cap
bites, which of the 20 components the library is strong and weak on, which subjects rest on
stronger evidence, and what kinds of study each subject is actually built from.